ArticleHuman genomics2026
A consensus model for implementation of genomics in Queensland Health - a Delphi study.
Article in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAs genomic technologies in healthcare expand, health systems face integration challenges. This study aimed to consolidate collective expertise, experiences, and existing knowledge from local, statewide, and national genomics projects to inform a model of care for integrating and delivering genomic services in the Queensland public health system.
methodsWe used a modified Delphi methodology with three survey rounds to achieve expert consensus on the model of care. We analysed quantitative data using descriptive statistics and qualitative data using content analysis.
resultsFrom 112 invited experts, 43 participants took part. The model of care comprised 30 actions across three phases: pre-test, testing, and post-test. Consensus (≥ 75% agreement) was achieved on 25 of the actions, with 5 included with specific considerations. Ten recommendations were developed, including building sustainability, improving access to specialists through a distributed model, and investing in clinical-pathology partnerships and infrastructures.
conclusionThese findings may inform a comprehensive, stakeholder-informed, system-level implementation effort for mainstreaming genomic medicine that is practical, feasible, and acceptable to key stakeholders across the system. The three-phase model of care provides a structured approach to genomic service delivery and has the potential to significantly improve patient access and healthcare delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.